Ken Griffin Merrimack Pharmaceuticals Inc Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

Shares

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 15, 2024	BUY	$13.06 - $15.0 $5,798 - $6,660	444 New	444 $6,000
Q3 2023 Nov 14, 2023	SELL	$11.6 - $12.52 $3,468 - $3,743	-299 Reduced 8.09%	3,398 $41,000
Q2 2023 Aug 14, 2023	SELL	$12.02 - $13.07 $57,623 - $62,657	-4,794 Reduced 56.46%	3,697 $45,000
Q1 2023 May 15, 2023	BUY	$11.35 - $12.32 $96,372 - $104,609	8,491 New	8,491 $104,000
Q3 2022 Nov 14, 2022	SELL	$3.7 - $6.06 $9,224 - $15,107	-2,493 Reduced 15.38%	13,718 $51,000
Q2 2022 Aug 15, 2022	BUY	$4.89 - $7.13 $27,330 - $39,849	5,589 Added 52.62%	16,211 $97,000
Q3 2021 Nov 15, 2021	SELL	$4.3 - $6.39 $36,679 - $54,506	-8,530 Reduced 44.54%	10,622 $51,000
Q2 2021 Aug 16, 2021	SELL	$6.04 - $7.77 $9,615 - $12,369	-1,592 Reduced 7.67%	19,152 $122,000
Q1 2021 May 17, 2021	SELL	$6.15 - $8.7 $7,373 - $10,431	-1,199 Reduced 5.46%	20,744 $130,000
Q4 2020 Feb 16, 2021	BUY	$3.69 - $8.31 $43,914 - $98,897	11,901 Added 118.51%	21,943 $151,000
Q4 2019 Feb 14, 2020	SELL	$3.15 - $4.67 $11,299 - $16,751	-3,587 Reduced 26.32%	10,042 $31,000
Q3 2019 Nov 14, 2019	BUY	$4.16 - $6.05 $707 - $1,028	170 Added 1.26%	13,629 $61,000
Q2 2019 Aug 14, 2019	SELL	$4.39 - $5.66 $15,422 - $19,883	-3,513 Reduced 20.7%	13,459 $82,000
Q4 2018 Feb 14, 2019	SELL	$2.95 - $4.15 $2,731 - $3,842	-926 Reduced 5.17%	16,972 $51,000
Q3 2018 Nov 13, 2018	SELL	$3.91 - $4.66 $30,290 - $36,101	-7,747 Reduced 30.21%	17,898 $0
Q2 2018 Aug 10, 2018	BUY	$3.86 - $7.61 $98,989 - $195,158	25,645 New	25,645 $0
Q1 2018 May 11, 2018	SELL	$6.24 - $9.15 $73,295 - $107,475	-11,746 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$7.99 - $11.87 $6,447 - $9,579	-807 Reduced 6.43%	11,746 $120,000
Q3 2017 Nov 09, 2017	BUY	$9.13 - $11.72 $114,608 - $147,121	12,553	12,553 $183,000

Others Institutions Holding MACK

# of Institutions

2

Shares Held

349

Call Options Held

0

Put Options Held

0

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.